|Biologic DMARDs (IL-1 and IL-6 inhibitors) are conditionally recommended as initial monotherapy.|Very low|PICO 22. In patients with treatment-naive, newly diagnosed systemic JIA without MAS, should biologic treatment (anakinra, canakinumab, tocilizumab, or others) be used as initial therapy, and is there a preferred order?|69â€“71|
|There is no preferred agent.| | | |